Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis
- PMID: 29559972
- PMCID: PMC5845642
- DOI: 10.3389/fimmu.2018.00402
Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis
Abstract
Our increasing appreciation of adenosine as an endogenous signaling molecule that terminates inflammation has generated excitement regarding the potential to target adenosine receptors (ARs) in the treatment of multiple sclerosis (MS), a disease of chronic neuroinflammation. Of the four G protein-coupled ARs, A2ARs are the principal mediator of adenosine's anti-inflammatory effects and accordingly, there is a growing body of evidence surrounding the role of A2ARs in experimental autoimmune encephalomyelitis (EAE), the dominant animal model of MS. Such evidence points to a complex, often paradoxical role for A2ARs in the immunopathogenesis of EAE, where they have the ability to both exacerbate and alleviate disease severity. This review seeks to interpret these paradoxical findings and evaluate the therapeutic promise of A2ARs. In essence, the complexities of A2AR signaling arise from two properties. Firstly, A2AR signaling downregulates the inflammatory potential of TH lymphocytes whilst simultaneously facilitating the recruitment of these cells into the CNS. Secondly, A2AR expression by myeloid cells - infiltrating macrophages and CNS-resident microglia - has the capacity to promote both tissue injury and repair in chronic neuroinflammation. Consequently, the therapeutic potential of targeting A2ARs is greatly undermined by the risk of collateral tissue damage in the periphery and/or CNS.
Keywords: adenosine; adenosine 2A receptor; experimental autoimmune encephalomyelitis; microglia; multiple sclerosis; neuroinflammation.
Figures

Similar articles
-
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.J Neuroinflammation. 2016 Feb 26;13:48. doi: 10.1186/s12974-016-0512-z. J Neuroinflammation. 2016. PMID: 26920550 Free PMC article.
-
A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.J Immunol. 2012 Jun 1;188(11):5713-22. doi: 10.4049/jimmunol.1200545. Epub 2012 Apr 23. J Immunol. 2012. PMID: 22529293 Free PMC article.
-
Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.Mol Neurobiol. 2017 Jul;54(5):3271-3285. doi: 10.1007/s12035-016-9893-3. Epub 2016 Apr 30. Mol Neurobiol. 2017. PMID: 27130268
-
The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.J Neuroimmunol. 2018 May 15;318:1-7. doi: 10.1016/j.jneuroim.2018.02.015. Epub 2018 Feb 27. J Neuroimmunol. 2018. PMID: 29606295 Review.
-
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.J Mol Med (Berl). 1997 Mar;75(3):165-73. doi: 10.1007/s001090050101. J Mol Med (Berl). 1997. PMID: 9106073 Review.
Cited by
-
Protective and therapeutic potentials of HDL and ApoA1 in COVID-19 elderly and chronic illness patients.Bull Natl Res Cent. 2022;46(1):222. doi: 10.1186/s42269-022-00886-x. Epub 2022 Jul 28. Bull Natl Res Cent. 2022. PMID: 35915785 Free PMC article. Review.
-
The Future of PET Imaging in Multiple Sclerosis: Characterisation of Individual White Matter Lesions.J Clin Med. 2025 Jun 23;14(13):4439. doi: 10.3390/jcm14134439. J Clin Med. 2025. PMID: 40648813 Free PMC article. Review.
-
Caffeine and Its Antioxidant Properties-It Is All about Dose and Source.Int J Mol Sci. 2022 Oct 28;23(21):13074. doi: 10.3390/ijms232113074. Int J Mol Sci. 2022. PMID: 36361861 Free PMC article. Review.
-
Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration.Front Pharmacol. 2021 Apr 13;12:654489. doi: 10.3389/fphar.2021.654489. eCollection 2021. Front Pharmacol. 2021. PMID: 33927630 Free PMC article. Review.
-
Adenosine signaling: a potential therapeutic target for psychogenic erectile dysfunction.Am J Transl Res. 2024 Dec 15;16(12):7248-7261. doi: 10.62347/YZDZ1428. eCollection 2024. Am J Transl Res. 2024. PMID: 39822506 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical